1. Home
  2. TRP vs EW Comparison

TRP vs EW Comparison

Compare TRP & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRP
  • EW
  • Stock Information
  • Founded
  • TRP 1951
  • EW 1958
  • Country
  • TRP Canada
  • EW United States
  • Employees
  • TRP N/A
  • EW N/A
  • Industry
  • TRP
  • EW Industrial Specialties
  • Sector
  • TRP
  • EW Health Care
  • Exchange
  • TRP Nasdaq
  • EW Nasdaq
  • Market Cap
  • TRP 49.3B
  • EW 44.8B
  • IPO Year
  • TRP N/A
  • EW 2000
  • Fundamental
  • Price
  • TRP $48.14
  • EW $76.79
  • Analyst Decision
  • TRP Hold
  • EW Buy
  • Analyst Count
  • TRP 3
  • EW 20
  • Target Price
  • TRP $62.00
  • EW $80.20
  • AVG Volume (30 Days)
  • TRP 3.5M
  • EW 3.6M
  • Earning Date
  • TRP 07-31-2025
  • EW 07-23-2025
  • Dividend Yield
  • TRP 5.20%
  • EW N/A
  • EPS Growth
  • TRP 60.55
  • EW 200.69
  • EPS
  • TRP 2.93
  • EW 7.02
  • Revenue
  • TRP $9,660,138,445.00
  • EW $5,522,300,000.00
  • Revenue This Year
  • TRP $7.07
  • EW $11.81
  • Revenue Next Year
  • TRP $8.92
  • EW $9.54
  • P/E Ratio
  • TRP $16.45
  • EW $31.73
  • Revenue Growth
  • TRP 8.07
  • EW 8.23
  • 52 Week Low
  • TRP $37.07
  • EW $58.93
  • 52 Week High
  • TRP $51.99
  • EW $95.25
  • Technical
  • Relative Strength Index (RSI)
  • TRP 43.94
  • EW 53.38
  • Support Level
  • TRP $46.89
  • EW $76.30
  • Resistance Level
  • TRP $50.09
  • EW $78.07
  • Average True Range (ATR)
  • TRP 0.96
  • EW 1.49
  • MACD
  • TRP -0.02
  • EW 0.14
  • Stochastic Oscillator
  • TRP 42.70
  • EW 71.52

About TRP TC Energy Corporation

TC Energy operates natural gas, oil, and power generation assets in Canada and the United States. The firm operates more than 60,000 miles of oil and gas pipelines, more than 650 billion cubic feet of natural gas storage, and about 4,300 megawatts of electric power.

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Share on Social Networks: